AI Pulse Check panelists say most manufacturers aren’t ready, static AI models likely stay central, and local AI deployment ...
How confident is the bio/pharma workforce heading into 2027? PharmTech wants to find out, and we need your input.
First-in-indication approval introduces a brain-penetrant oral small molecule for GD3 neurologic symptoms, distinguishing it ...
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J.
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s ...
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing ...
Trump withdraws FDA commissioner nominee Heidi Overton, extending a leadership gap that leaves review and launch timelines ...
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, breaks down the company’s one-pot technology for mRNA ...
Nate Edwards of Arya Consulting, Elisabeth Gardiner of Tevard Biosciences, and Donny Xu of the RTW Institute discuss global competition for rare disease therapies.
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase ...